MariMed (MRMD) Short Interest Ratio & Short Volume $0.07 0.00 (-4.15%) As of 05/23/2025 03:56 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock MariMed Short Interest DataMariMed (MRMD) has a short interest of 51,300 shares. This marks a -11.25% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 413,416 shares to cover all short positions.Current Short Interest51,300 sharesPrevious Short Interest57,800 sharesChange Vs. Previous Month-11.25%Dollar Volume Sold Short$5,463.45Short Interest Ratio0.1 Days to CoverLast Record DateApril 30, 2025Outstanding Shares388,710,000 sharesPercentage of Shares Shorted0.01%Today's Trading Volume741,349 sharesAverage Trading Volume413,416 sharesToday's Volume Vs. Average179% Short Selling MariMed? Sign up to receive the latest short interest report for MariMed and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMRMD Short Interest Over TimeMRMD Days to Cover Over TimeMRMD Percentage of Float Shorted Over Time MariMed Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202551,300 shares $5,463.45 -11.3%N/A0.1 $0.11 4/15/202557,800 shares $4,855.20 -10.5%0.0%0.1 $0.08 3/31/202564,600 shares $6,072.40 +12.7%0.0%0.1 $0.09 3/15/202557,300 shares $5,901.90 -63.1%0.0%0.1 $0.10 2/28/2025155,100 shares $17,634.87 +12.2%0.1%0.2 $0.11 2/15/2025138,300 shares $20,717.34 +70.7%0.0%0.1 $0.15 1/31/202581,000 shares $9,112.50 +39.4%N/A0.1 $0.11 1/15/202558,100 shares $6,460.72 +868.3%N/A0.1 $0.11 12/31/20246,000 shares $694.80 -93.5%N/A0 $0.12 12/15/202491,800 shares $12,002.85 +3,178.6%N/A0.1 $0.13 Get the Latest News and Ratings for MRMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter. 11/30/20242,800 shares $410.20 -96.0%N/A0 $0.15 11/15/202469,900 shares $11,079.15 +147.9%N/A0.1 $0.16 10/31/202428,200 shares $4,512.00 -77.5%N/A0 $0.16 10/15/2024125,500 shares $20,393.75 +302.2%N/A0.1 $0.16 9/30/202431,200 shares $5,366.40 -31.9%N/A0.1 $0.17 9/15/202445,800 shares $7,648.60 +77.5%N/A0.1 $0.17 8/31/202425,800 shares $4,785.90 -49.7%N/A0 $0.19 8/15/202451,300 shares $13,568.85 +370.6%N/A0 $0.26 7/31/202410,900 shares $1,948.92 +990.0%N/A0 $0.18 7/15/20241,000 shares $163.00 -83.3%N/A0 $0.16 6/30/20246,000 shares $1,086.00 +400.0%N/A0 $0.18 6/15/20241,200 shares $231.53 -95.7%N/A0 $0.19 5/31/202427,900 shares $5,996.69 +210.0%N/A0 $0.21 5/15/20249,000 shares $2,286.00 +5.9%N/A0 $0.25 4/30/20248,500 shares $2,762.08 -44.4%N/A0 $0.32 4/15/202415,300 shares $3,978.00 -55.5%N/A0 $0.26 3/31/202434,400 shares $9,083.66 -35.3%N/A0 $0.26 3/15/202453,200 shares $13,832.00 +198.9%N/A0 $0.26 2/29/202417,800 shares $4,859.40 +74.5%N/A0 $0.27 2/15/202410,200 shares $2,897.82 -46.6%N/A0 $0.28 1/15/202429,600 shares $9,294.40 -49.6%N/A0 $0.31 12/31/202358,700 shares $16,130.76 +136.7%N/A0.1 $0.27 12/15/202324,800 shares $7,363.12 +34.8%N/A0.1 $0.30 11/30/202318,400 shares $5,439.04 +109.1%N/A0 $0.30 11/15/20238,800 shares $2,640.00 -65.8%N/A0 $0.30 10/31/202325,700 shares $8,686.60 +192.1%N/A0 $0.34 10/15/20238,800 shares $3,361.60 -66.2%N/A0 $0.38 9/30/202326,000 shares $11,324.30 -49.2%N/A0 $0.44 9/15/202351,200 shares $26,112.00 +76.6%N/A0 $0.51 8/31/202329,000 shares $12,310.50 +19.3%N/A0 $0.42$19 for a FULL YEAR of stock picks?! (Ad)Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. Discover how a $100 investment could give you exposure to Musk's private AI project — via one overlooked stock.Watch the exclusive AI investor briefing >>> 8/15/202324,300 shares $6,585.30 -39.3%N/A0 $0.27 7/31/202340,000 shares $15,220.00 +141.0%N/A0.1 $0.38 7/15/202316,600 shares $6,690.63 -30.5%N/A0 $0.40 6/30/202323,900 shares $9,799.00 +94.3%N/A0.1 $0.41 6/15/202312,300 shares $4,880.03 +38.2%N/A0 $0.40 5/31/20238,900 shares $3,604.50 -51.1%N/A0 $0.41 5/15/202318,200 shares $8,180.90 +13.8%N/A0 $0.45 4/30/202316,000 shares $6,120.00 +100.0%N/A0 $0.38 4/15/20238,000 shares $3,040.00 -65.5%N/A0 $0.38 3/31/202323,200 shares $9,106.00 -18.9%N/A0 $0.39 3/15/202328,600 shares $12,298.00 +140.3%N/A0.1 $0.43 2/28/202311,900 shares $5,126.52 +35.2%N/A0 $0.43 2/15/20238,800 shares $3,826.24 -8.3%N/A0 $0.43 1/31/20239,600 shares $3,932.16 No ChangeN/A0 $0.41 1/15/20239,600 shares $4,029.12 +7.9%N/A0 $0.42 12/30/20228,900 shares $3,169.74 -10.1%N/A0 $0.36 12/15/20229,900 shares $3,910.50 -23.3%N/A0 $0.40 11/30/202212,900 shares $6,856.35 -68.4%N/A0 $0.53 11/15/202240,800 shares $23,309.04 +29.9%N/A0.1 $0.57 10/31/202231,400 shares $17,270.00 +25.6%N/A0.1 $0.55 10/15/202225,000 shares $13,875.00 +138.1%N/A0 $0.56 9/30/202210,500 shares $4,549.65 -83.9%N/A0 $0.43 9/15/202265,300 shares $34,935.50 +251.1%N/A0.1 $0.54 8/31/202218,600 shares $11,346.00 +24.0%N/A0 $0.61 8/15/202215,000 shares $9,825.00 -19.4%N/A0 $0.66 7/31/202218,600 shares $13,485.00 -3.6%N/A0 $0.73 7/15/202219,300 shares $13,510.00 +107.5%N/A0 $0.70 6/30/20229,300 shares $4,371.00 +1.1%N/A0 $0.47 6/15/20229,200 shares $4,784.00 -19.3%N/A0 $0.52 5/31/202211,400 shares $6,954.00 -79.3%N/A0 $0.61 5/15/202255,100 shares $34,162.00 +392.0%N/A0 $0.62 4/30/202211,200 shares $7,168.00 -76.5%N/A0 $0.64 4/15/202247,700 shares $34,577.73 +203.8%N/A0.1 $0.72 3/31/202215,700 shares $11,461.00 -14.2%N/A0 $0.73 3/15/202218,300 shares $13,313.25 -30.9%N/A0 $0.73 2/28/202226,500 shares $20,670.00 +29.9%N/A0 $0.78 2/15/202220,400 shares $16,575.00 -93.5%N/A0 $0.81 1/31/2022313,500 shares $244,530.00 +3.1%N/A0.2 $0.78 1/15/2022304,000 shares $251,712.00 -4.5%N/A0.3 $0.83 12/31/2021318,400 shares $275,416.00 -26.1%N/A0.3 $0.87 12/15/2021430,600 shares $307,233.10 +32.9%N/A0.3 $0.71 11/30/2021324,000 shares $226,800.00 +4.0%N/A0.2 $0.70 11/15/2021311,500 shares $292,810.00 +0.3%N/A0.2 $0.94 10/29/2021310,500 shares $229,770.00 +0.8%N/A0.2 $0.74 10/15/2021308,000 shares $256,256.00 +26.8%N/A0.4 $0.83 9/30/2021243,000 shares $218,700.00 -0.4%N/A0.2 $0.90 9/15/2021243,900 shares $247,558.50 -1.0%N/A0.3 $1.02 8/31/2021246,300 shares $235,241.13 +1.0%N/A0.1 $0.96 8/13/2021243,900 shares $217,314.90 -1.0%N/A0.4 $0.89 7/30/2021246,300 shares $211,029.84 +29.9%N/A0.3 $0.86Buffett’s $325 Billion Cash Problem — Solved by Gold? (Ad)A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late. Discover how you could front-run Buffett’s gold move with Garrett’s Top Four picks. 7/15/2021189,600 shares $159,282.96 -59.7%N/A0.2 $0.84 6/30/2021470,400 shares $443,822.40 -8.6%N/A0.4 $0.94 6/15/2021514,600 shares $496,589.00 -12.0%N/A0.3 $0.97 5/28/2021588,000 shares $646,800.00 -0.9%N/A0.2 $1.10 5/14/2021593,400 shares $456,502.62 -2.0%N/A0.5 $0.77 4/30/2021605,700 shares $448,218.00 +4.5%N/A0.5 $0.74 4/15/2021579,700 shares $394,196.00 -0.4%N/A0.6 $0.68 3/31/2021582,100 shares $424,933.00 -3.0%N/A0.3 $0.73 3/15/2021600,000 shares $477,300.00 +2.5%N/A0.4 $0.80 2/26/2021585,300 shares $433,063.47 -8.7%N/A0.3 $0.74 2/12/2021640,800 shares $608,824.08 +8.2%N/A0.1 $0.95 1/29/2021592,200 shares $411,966.89 -16.1%N/A0.1 $0.70 1/15/2021580,000 shares $464,849.70 -62.5%N/A0.1 $0.80 12/31/2020583,600 shares $250,948.00 +0.6%N/A0.2 $0.43 12/15/2020580,000 shares $187,427.00 -62.5%N/A0.1 $0.32 11/30/20201,547,500 shares $586,502.50 -49.3%N/A0.3 $0.38 11/15/20203,052,000 shares $511,210.00 -17.3%N/A0.7 $0.17 10/30/20203,691,200 shares $524,519.52 +5.4%N/A1.5 $0.14 10/15/20203,503,300 shares $541,610.18 -1.1%N/A1.6 $0.15 9/30/20203,543,400 shares $571,550.42 +5.1%N/A2.6 $0.16 9/15/20203,372,800 shares $602,044.80 +2.4%N/A1.2 $0.18 8/31/20203,294,000 shares $597,202.20 -4.9%N/A1.2 $0.18 8/14/20203,463,600 shares $676,441.08 -18.8%N/A1.2 $0.20 7/31/20204,265,500 shares $597,170.00 +0.2%N/A2.7 $0.14 7/15/20204,258,000 shares $597,397.40 +8.5%N/A2.1 $0.14 6/30/20203,923,900 shares $616,444.69 -2.2%N/A2 $0.16 6/15/20204,010,700 shares $721,926.00 +0.8%N/A1.1 $0.18 5/29/20203,980,100 shares $716,418.00 +3.1%N/A0.8 $0.18 MRMD Short Interest - Frequently Asked Questions What is MariMed's current short interest? Short interest is the volume of MariMed shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 51,300 shares of MRMD short. Learn More on MariMed's current short interest. Is MariMed's short interest increasing or decreasing? MariMed saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 51,300 shares, a decline of 11.2% from the previous total of 57,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does MariMed's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to MariMed: Compugen Ltd. (1.93%), Lyell Immunopharma, Inc. (4.53%), Black Diamond Therapeutics, Inc. (16.60%), Atossa Therapeutics, Inc. (5.52%), Theratechnologies Inc. (2.20%), InflaRx (1.68%), Janone Inc. (2.84%), Neumora Therapeutics, Inc. (19.86%), Lexeo Therapeutics, Inc. (13.02%), Vigil Neuroscience, Inc. (1.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short MariMed stock? Short selling MRMD is an investing strategy that aims to generate trading profit from MariMed as its price is falling. MRMD shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MariMed? A short squeeze for MariMed occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MRMD, which in turn drives the price of the stock up even further. How often is MariMed's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRMD, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Compugen Short Interest Lyell Immunopharma Short Interest Black Diamond Therapeutics Short Interest Atossa Therapeutics Short Interest Theratechnologies Short Interest InflaRx Short Interest Janone Short Interest Neumora Therapeutics Short Interest Lexeo Therapeutics Short Interest Vigil Neuroscience Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:MRMD) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMarket chaos is the new normalIt happened again. Wall Street swung like a wrecking ball after Trump paused tariffs on smartphones, lapto...Augusta Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MariMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MariMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRMD Stock Free MRMD Stock Alerts